{"filing":{"accession_number":"0001193125-26-230425","cik":"0001668397","ticker":null,"company_name":"Medpace Holdings, Inc.","form":"8-K","filing_date":"2026-05-19","report_date":null,"primary_document":"d101911d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1668397/000119312526230425/d101911d8k.htm"},"classifications":[{"id":141,"accession_number":"0001193125-26-230425","item_number":"5.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"The disclosure describes stockholder-approved amendments to the Restated Certificate of Incorporation removing supermajority voting requirements and limitations on special meetings, along with conforming bylaw amendments. While Item 5.03 is the standard disclosure vehicle for charter and bylaw amendments, these changes materially alter the Company's governance structure by reducing voting thresholds and expanding stockholder rights to call special meetings—changes that would affect a reasonable investor's assessment of corporate control and governance. This does not fit the more specific event types in the taxonomy.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:18:17.853660+00:00","company_name":"Medpace Holdings, Inc.","ticker":null,"filing_date":"2026-05-19"},{"id":142,"accession_number":"0001193125-26-230425","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes from the May 15, 2026 Annual Meeting across seven proposals, including director elections (Brian T. Carley, Femida H. Gwadry-Sridhar, Robert O. Kraft, August J. Troendle, Dani S. Zander), ratification of Deloitte \u0026 Touche LLP as auditor, advisory votes on executive compensation and voting frequency, and two Certificate of Incorporation amendments. The detailed vote tallies and Board determination regarding annual advisory votes on compensation are material to investors assessing governance and board composition.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:18:17.853660+00:00","company_name":"Medpace Holdings, Inc.","ticker":null,"filing_date":"2026-05-19"}]}